Literature DB >> 15019264

Restriction fragment length polymorphism of L1 amplicon using Rsa 1 detects five different human papillomavirus types and their co-infections among women attending a gynaecological outpatient department.

Samar Husain Naqvi1, Saima Wajid, Ardhendu B Mitra.   

Abstract

Detection of human papillomavirus (HPV) types 6, 11, 16, 18, and 33 including co-infections among females attending gynaecological outpatient department and cancer clinics, was done by restriction fragment length polymorphism (using Rsa-1), of approximately 450bp amplicon, obtained by the amplification of the L1 region of HPV genome with consensus primers MY09/11 [Cancer Cells 7 (1989) 209]. The results were further tested with HPV type specific primers [J. Med. Virol. 29 (1989) 20]. The technique was found to be low-cost and less time consuming. The advantage of Rsa 1 over other enzymes was that it detects the five most prevalent HPV types commonly associated with warts, cervical dysplasia, and cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019264     DOI: 10.1016/j.jviromet.2003.12.002

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  3 in total

Review 1.  A review of methods for detect human Papillomavirus infection.

Authors:  André L P Abreu; Raquel P Souza; Fabrícia Gimenes; Marcia E L Consolaro
Journal:  Virol J       Date:  2012-11-06       Impact factor: 4.099

2.  Distribution of HPV Genotypes and Involvement of Risk Factors in Cervical Lesions and Invasive Cervical Cancer: A Study in an Indian Population.

Authors:  Shikha Srivastava; U P Shahi; Arti Dibya; Sadhana Gupta; Jagat K Roy
Journal:  Int J Mol Cell Med       Date:  2014

3.  Molecular Detection and Typing of Human Papillomaviruses in Paraffin-Embedded Cervical Cancer and Pre-Cancer Tissue Specimens.

Authors:  Pezhman Mahmoodi; Hossein Motamedi; Masoud Reza Seyfi Abad Shapouri; Mahjabin Bahrami Shehni; Mohammad Kargar
Journal:  Iran J Cancer Prev       Date:  2016-02-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.